Garry Meakin

5PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Optical technologyInnate immunityObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homes.

Philip M Bath, Jonathan Ball, Matthew Boyd

|Mar 27, 2022
Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.

Paul Leighton, Joanne R Chalmers, Jonathan M Batchelor

|Nov 27, 2020
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.

Jonathan M Batchelor, Kim S Thomas, Perways Akram

|Sep 13, 2020
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).

T H Sach, K S Thomas, J M Batchelor

|May 18, 2019
Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.

Jonathan Dc Ross, Jan Harding, Lelia Duley

Pageof 1

Frequent Collaborators

4 joint publications

Alan Montgomery

3 joint publications

Tracey H Sach

3 joint publications

Kim S Thomas

3 joint publications

Jonathan M Batchelor